%0 Journal Article
%A López-Díaz, Álvaro
%A Murillo-Izquierdo, Manuel
%A Moreno-Mellado, Elisa
%T Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
%D 2019
%U http://hdl.handle.net/10668/13886
%X Ketamine therapy for treatment-resistant depression in European national health systems may only be considered after attempting all evidence-based antidepressant strategies outlined in clinical guidelines. This paper seeks to explain the ethical, regulatory and procedural framework for the off-label use of ketamine for treatment-resistant depression within a public healthcare system.Declaration of interestNone.
%K Treatment-resistant depression
%K antidepressants
%K ketamine
%~